Quality by design- newer technique for pharmaceutical product development
Regulatory bodies are nowadays concerned with pharmaceutical drug products' safety, efficacy, and quality. Quality is the priority of all regulatory bodies, it is a high priority for the triple P factor (patient, pharmacist, and physician). It links pharmaceutical industries and regulatory authoriti...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
KeAi Communications Co., Ltd.
2024-02-01
|
| Sarja: | Intelligent Pharmacy |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2949866X23000953 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|